Synthesis and in vitro antitumor activity of some new Mannich bases
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Kandeel M.M. | |
dc.contributor.author | Abdou N.A. | |
dc.contributor.author | Kadry H.H. | |
dc.contributor.author | El-Masry R.M. | |
dc.contributor.other | Pharmaceutical Organic Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Cairo | |
dc.contributor.other | 11562 | |
dc.contributor.other | Egypt; Organic Chemistry Department | |
dc.contributor.other | October University for Modern Sciences and Arts | |
dc.contributor.other | 6 October City | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:42:29Z | |
dc.date.available | 2020-01-09T20:42:29Z | |
dc.date.issued | 2013 | |
dc.description | Scopus | |
dc.description.abstract | Two series of Novel Mannich bases has been synthesized from chalcones 3 and 7 and evaluated for their in vitro cytotoxic activity. Out of the newly synthesized compounds, four derivatives 4a, 4b, 4e, 4f were selected by the National Cancer Institute (NCI) to be evaluated for their in-vitro antitumor activity by in-vitro disease-oriented human cells screening panel assay. All the tested compounds exhibited a broad spectrum of antitumor activity against renal cancer UO-31. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=19700175055&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/ | |
dc.identifier.issn | 9744290 | |
dc.identifier.other | https://doi.org/ | |
dc.identifier.uri | https://t.ly/2dwYb | |
dc.language.iso | English | en_US |
dc.relation.ispartofseries | International Journal of ChemTech Research | |
dc.relation.ispartofseries | 5 | |
dc.subject | Antitumor activity | en_US |
dc.subject | Chalcones | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Mannich bases | en_US |
dc.subject | Synthesis | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | chalcone derivative | en_US |
dc.subject | Mannich base | en_US |
dc.subject | antineoplastic activity | en_US |
dc.subject | article | en_US |
dc.subject | cell count | en_US |
dc.subject | colon cancer | en_US |
dc.subject | controlled study | en_US |
dc.subject | cytotoxicity | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | growth inhibition | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | infrared spectrophotometry | en_US |
dc.subject | kidney cancer | en_US |
dc.subject | mass fragmentography | en_US |
dc.subject | melting point | en_US |
dc.subject | microanalysis | en_US |
dc.subject | proton nuclear magnetic resonance | en_US |
dc.subject | thin layer chromatography | en_US |
dc.title | Synthesis and in vitro antitumor activity of some new Mannich bases | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Dimmock, J.R., Kandepu, N.M., Hetherington, M., Quail, J.W., Pugazhenthi, U., Sudom, A.M., Chamankhah, M., Balzarini, J., Cytotoxic Activities of Mannich Bases of Chalcones and Related Compounds (1998) J. Med. Chem, 41, pp. 1014-1026; Gul, H.I., Yerdelen, K.O., Gul, M., Das, U., Pandit, B., Li, P.K., Secen, H., Sahin, F., Synthesis of 4'-Hydroxy-3'- piperidinomethylchalcone derivatives and their cytotoxicity against PC-3 cell lines (2007) Arch. Pharm. Chem. Life Sci, 340, pp. 195-201; Gul, H.I., Yerdelen, K.O., Das, U., Gul, M., Pandit, B., Li, P.K., Dimmock, J.R., Synthesis and Cytotoxicity of Novel 3-Aryl-1-(3'- dibenzylaminomethyl-4'-hydroxyphenyl)- propenones and Related Compounds (2008) Chem. Pharm. Bull, 56, pp. 1675-1681; Hieu, B.T., Thuy, L.T., Thuy, V.T., Tien, H.X., Chinh, L.V., Hoang, V.D., Vu, T.K., Design, Synthesis and In Vitro Cytotoxic Activity Evaluation of New Mannich Bases (2012) Bull Korean Chem Soc, 33, pp. 1586-1592; Reddy, M.V.B., Sua, C.R., Chioub, W.F., Liuc, Y.N., Chenc, R.Y.H., Bastowc, K.F., Leec, K.H., Wua, T.S., Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents (2008) Bioorg & Med. Chem, 16, pp. 7358-7370; Hua, G., Wang, G., Duana, N., Wena, X., Caoa, T., Xiea, S., Huangb, W., Design, synthesis and antitumor activities of fluoroquinolone C-3 heterocycles (IV): S-triazole Schiff-Mannich bases derived from ofloxacin (2012) Acta Pharmaceutica Sinica B, 2, pp. 312-317; Shawa, A.Y., Changa, C.Y., Hsua, M.Y., Lub, P.J., Yangc, C.N., Chenb, H.L., Loc, C.W., Cherna, M.K., Synthesis and structure-activity relationship study of 8- hydroxyquinoline-derived Mannich bases as anticancer agents (2010) Eur. J. Med. Chem, 45, pp. 2860-2867; Reddy, M.V.B., Shen, Y.C., Yang, J.S., Hwang, T.L., Bastow, K.F., Qian, K., Lee, K.H., Wua, T.S., New bichalcone analogs as NF-jB inhibitors and as cytotoxic agents inducing Fas/CD95-dependent apoptosis (2011) Bioorg & Med. Chem, 19, pp. 1895-1906; Dimmock, J.R., Advikolanu, K.M., Scott, H.E., Duffy, M.J., Reid, R.S., Quail, J.W., Jia, Z., Rutledge, J.M., Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazones (1992) J. Pharm. Sci, 81, pp. 1147-1152; Dimmock, J.R., Kumar, P., Anticancer and Cytotoxic Properties of Mannich Bases (1997) Curr. Med. Chem, 4, pp. 1-22; Kumar, D., Kumar, N.M., Akamatsu, K., Kusaka, E., Harada, H., Ito, T., Synthesis and biological evaluation of indolyl chalcones as antitumor agents (2010) Bioorg & Med. Chem. Lett, 20, pp. 3916-3919; Bamnela, R., Shrivastava, S.P., Synthesis and Biological Activity of 4, 6-Substituted aryl-1-acetyl pyrimidine-2-ols (2010) Asian J. Chem, 22, pp. 6553-6558; Grever, M.R., Schepartz, S.A., Chabner, B.A., The National Cancer Institute: Cancer drug discovery and development program (1992) Semin. Oncol, 19, pp. 622-638; Monks, A., Scudiero, D., Skehan, P., Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines (1991) J. Natl. Cancer Inst, 83, pp. 757-766; Boyd, M.R., Paull, K.D., Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen (1995) Drug Dev. Res, 34, pp. 91-109; Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.R., Boyd, M.R., New colorimetric cytotoxic assay for anticancer drug screening (1990) J. Natl. Cancer Inst, 82, pp. 1107-1112 | |
dcterms.source | Scopus |